Catalyst Pharmaceutical Research (CPR) Company Profile

03:47 EDT 24th March 2018 | BioPortfolio

Catalyst Pharmaceutical Research (CPR) is an integrated clinical research organization providing high-quality clinical research, biostatistics and data processing, regulatory, and licensing services support for pharmaceutical development. CPR's experienced staff applies industry proven information technology systems for rapid and reliable trial management, and electronic data capture and analysis, for Phase II and III multi-center international studies. This speeds project timelines, and reduces our clients overall development costs, while ensuring the highest level of security, accuracy and reliability


1111 S. Arroyo Pkwy., Suite 200
United States of America


Phone: 626-568-8645
Fax: 626-568-8667

News Articles [868 Associated News Articles listed on BioPortfolio]

STA to open catalyst screening centre in Changzhou in November

STA Pharmaceutical Co is setting up a metal catalyst-screening center at its facility in Changzhou, China.

Catalyst Pharmaceutical (CPRX) Presents At BIO CEO & Investor Conference - Slideshow

Global and Chinese Catalyst Industry, 2017 Market Research Report [Report Updated: 21122017] Prices from USD $3000

The 'Global and Chinese Catalyst Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Catalyst industry with a focus on the Chinese market....

Catalyst Pharmaceutical (CPRX) Presents At 2017 BIO Investor Forum - Slideshow

Highly efficient ammonia synthesis catalyst developed

Researchers have discovered that a catalyst of calcium amide with a small amount of added barium (Ba-Ca(NH2)2) with ruthenium nanoparticles immobilized onto it can synthesize ammonia at an efficiency ...

Virginia Tech Carilion Research Institute gets 'Catalyst' grant to curtail opioid epidemic

(Virginia Tech) A dual university project including the Virginia Tech Carilion Research Institute will focus on the opioid epidemic and receive $1 million in combined grant funding, according to an an...

Umicore to Buy Materia’s Metathesis Catalyst Arm

Belgian materials technology and recycling group Umicore has agreed to acquire the metathesis catalyst business of Pasadena, California-based Materia Inc., valuing the assets at $27 million. Umicore s...

Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q4 2017 Results - Earnings Call Transcript

PubMed Articles [1713 Associated PubMed Articles listed on BioPortfolio]

Enhanced visible light photodegradation of pharmaceutical pollutant, warfarin by nano-sized SnTe, effect of supporting, catalyst dose, and scavengers.

Improvement of new nanophotocatalysts enable to decompose the pharmaceutical pollutants with the aid of solar energy is of particular importance. In this research, the ability of SnTe photocatalyst fo...

The Infernal Alternatives of Corporate Pharmaceutical Research: Abandoning Psychiatry.

What happens when health research is measured by market size, how does this change the dynamics of medical research, and how is it growth envisioned and managed? Building on my arguments in Drugs for ...

The future of LC-MS for pharmaceutical analysis: an interview with Jun Qu.

Jun Qu speaks to Sankeetha Nadarajah, Editor of Bioanalysis: Jun Qu is the group leader of the proteomics and pharmaceutical analysis lab of SUNY-Buffalo (NY, USA) and a Professor in the Department of...

Guiding principles of value creation through collaborative innovation in pharmaceutical research.

Open innovation has become the main trend in pharmaceutical research. Potential obstacles and pitfalls of collaborations often lead to missed opportunities and/or poorly executed partnerships. This pa...

Patent Highlights April-May 2017.

A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.

Clinical Trials [1299 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care for Inpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant inpatients

Companies [3104 Associated Companies listed on BioPortfolio]

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

Catalyst Pharmaceutical Research (CPR)

Catalyst Pharmaceutical Research (CPR) is an integrated clinical research organization providing high-quality clinical research, biostatistics and data processing, regulatory, and licensing services s...

Catalyst Pharmaceutical Partners

Catalyst is a specialty pharmaceutical company of Coral Gables, Florida, that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction. Catalyst is d...

Catalyst Biomedica Limited

Catalyst BioMedica is a company that enables and supports the translation of fundamental biomedical research into innovative products and technologies that will meet global healthcare needs. Catalyst ...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

More Information about "Catalyst Pharmaceutical Research (CPR)" on BioPortfolio

We have published hundreds of Catalyst Pharmaceutical Research (CPR) news stories on BioPortfolio along with dozens of Catalyst Pharmaceutical Research (CPR) Clinical Trials and PubMed Articles about Catalyst Pharmaceutical Research (CPR) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Pharmaceutical Research (CPR) Companies in our database. You can also find out about relevant Catalyst Pharmaceutical Research (CPR) Drugs and Medications on this site too.

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record